MeadWestvaco Corp. (MWV), a global leader in packaging and packaging solutions, introduced Shellpak Renew with OptilockT technology. This smaller, more discreet medication adherence package is designed to meet patient and pharmacist needs ...
Tags: Packaging
Sagent Pharmaceuticals has re-introduced an antiarrhythmic agent Amiodarone HCl Injection as an improved prefilled plastic syringe compatible with standard I.V. pumps. Featuring Sagent's PreventIV Measures packaging and labeling to help ...
Tags: HCL Injection, Health
Specialty pharmaceutical company Sagent Pharmaceuticals has introduced an antineoplastic agent, Docetaxel Injection Concentrate, in three preservative-free vial presentations. Designed to help reduce medication errors, the product ...
Tags: Sagent, Medicine errors
Specialty pharmaceutical company Avion Pharmaceuticals has launched a prescription prenatal supplement with B vitamins and Ginger, Prenate AM, to ease pregnancy symptoms like nausea and vomiting in pregnancy (NVP). Avion CEO Mark Pugh ...
Tags: Prenatal Supplement, Medicine
Specialty pharmaceutical company Iroko Pharmaceuticals has announced the FDA acceptance for New Drug Application (NDA) filing of lower dose submicron Indomethacin, a non-steroidal anti-inflammatory drug. The proposed indication of the ...
Tags: FDA Acceptance, NDA Filing
Specialty pharmaceutical company Actavis has won FDA approval for abbreviated new drug application (ANDA) of generic equivalent to Endo Health Solutions' Opana ER. Oxymorphone Hydrochloride extended-release tablets, which is available in ...
Tags: FDA, ANDA, Generic Opana ER
Specialty pharmaceutical company Tris Pharma's generic pharmaceuticals business has launched Dextroamphetamine Sulfate Oral Solution to treat attention deficit disorder with hyperactivity (ADHD) and narcolepsy in the US. Available through ...
Tags: Tris Pharma, Medicine
Generic and specialty pharmaceutical company Mylan Pharmaceuticals has introduced a portfolio of women's healthcare products in India, expanding its product base in the country. Consisting of eight products initially, the portfolio is ...
Tags: Women's Care Products, Medicine
The US Food and Drug Administration (FDA) has accepted the new drug application (NDA)from DURECT, a specialty pharmaceutical company, for its Posidur (Saber-Bupivacaine) investigational candidate. Designed to offer up to three days of ...
Specialty pharmaceutical company TherapeuticsMD has obtained investigational new drug (IND) application clearance from the US Food and Drug Administration (FDA) for vaginal estradiol suppository, TX12-004HR. The IND acceptance will allow ...
Specialty pharmaceutical company Sun Pharmaceutical Industries has obtained final USFDA approval for the abbreviated new drug application of generic Depo-Testosterone Injection, Testosterone Cypionate Injection USP, 100mg/ml and 200mg/ml. ...
US-based specialty pharmaceutical company, pSivida has entered into a funded technology evaluation agreement with an undisclosed pharmaceutical company. The deal will assess the Durasert technology, pSivida's core technology system, for ...
Taiwan-based specialty pharmaceutical company TWi Pharmaceuticals has obtained FDA tentative approval for its abbreviated new drug application (ANDA) for Guanfacine Hydrochloride Extended Release tablets 1mg, 2mg, 3mg and 4mg. The central ...
Tags: TWi, FDA, pharmaceutical
Specialty pharmaceutical company Nuvo Research has announced the launch of Pliaglis (lidocaine and tetracaine) cream 7%/7% by Galderma in Europe. Galderma has worldwide marketing rights for Nuvo's Pliaglis, a topical local anesthetic ...
Tags: Nuvo Research, Pliaglis
The US Food and Drug Administration (FDA) has approved Warner Chilcott's new oral contraceptive MINASTRIN 24 FE. MINASTRIN 24 FE (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) is indicated for use by ...